REFERENCES
1. Mottet N, van den Bergh RCN, Briers E, et al. EAU - ESTRO - ESUR - SIOG Guidelines on Prostate Cancer 2020. European Association of Urology Guidelines. 2020 Edition. Vol presented at the EAU Annual Congress Amsterdam 2020. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2020.
2. Katims AB, Razdan S, Eilender BM, et al. Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable. Urologic Oncology: Seminars and Original Investigations : Elsevier; 2020.
3. Boorjian SA, Bianco Jr FJ, Scardino PT, Eastham JA. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy? BJU international. 2005;96:773-776.
4. Çelik S, Tınay İ, Narter F, et al. Management of Patients with Urological Cancers in Turkey during the COVID-19 Pandemic: Recommendations of Uro-oncology Association. Bull Urooncol.2020;19:100-103.
5. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of biomedical informatics.2009;42:377-381.
6. RT PH, Minor B, Elliott V. REDCap Consortium, the REDCap Consortium: building an international community of software partners.J Biomed Inform. 2019.
7. Davidson-Pilon C, Kalderstam J, Jacobson N, et al. CamDavidsonPilon/lifelines: v0. 25.4. Zenodo: Genève, Switzerland. 2020.
8. Deka R, Courtney PT, Parsons JK, et al. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. JAMA.2020;324:1747-1754.
9. Richard PO, Timilshina N, Komisarenko M, et al. The long-term outcomes of Gleason grade groups 2 and 3 prostate cancer managed by active surveillance: Results from a large population-based cohort. Canadian Urological Association Journal. 2020;14.
10. Zanaty M, Alnazari M, Ajib K, et al. Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort. World journal of urology.2018;36:1-6.
11. Gupta N, Bivalacqua TJ, Han M, et al. Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate‐risk to very‐high‐risk clinically localised prostate cancer. BJU international. 2019;124:268-274.
12. Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. British Journal of Cancer.2015;112:S92-S107.
13. Hollenbeck BK, Dunn RL, Ye Z, et al. Delays in diagnosis and bladder cancer mortality. Cancer. 2010;116:5235-5242.
14. Wallace D, Bryan R, Dunn J, Begum G, Bathers S, Group WMUR. Delay and survival in bladder cancer. BJU international.2002;89:868-878.
15. Akdas A, Kirkah Z, Remzi D. The Role of Delay in Stage-Ill Testicular Tumors. European urology. 1986;12:151-153.
16. Huyghe E, Muller A, Mieusset R, et al. Impact of diagnostic delay in testis cancer: results of a large population-based study.European urology. 2007;52:1710-1716.
17. Dieckmann K-P, Becker T, Bauer H. Testicular tumors: presentation and role of diagnostic delay. Urologia internationalis. 1987;42:241-247.
18. Meffan P, Delahunt B, Nacey J. The value of early diagnosis in the treatment of patients with testicular cancer. The New Zealand Medical Journal. 1991;104:393-394.
19. Laguna MP, Albers P, Algaba F, et al. EAU Guidelines on Testicular Cancer 2020. European Association of Urology Guidelines. 2020 Edition. Vol presented at the EAU Annual Congress Amsterdam 2020. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2020.
20. Volpe A, Cadeddu JA, Cestari A, et al. Contemporary management of small renal masses. European urology.2011;60:501-515.
21. Van Poppel H, Joniau S. Is surveillance an option for the treatment of small renal masses? European urology.2007;52:1323-1330.
22. Bourgade V, Drouin SJ, Yates DR, et al. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival. World journal of urology. 2014;32:475-479.
23. Zanaty M, Alnazari M, Lawson K, et al. Does surgical delay for radical prostatectomy affect patient pathological outcome? A retrospective analysis from a Canadian cohort. Canadian Urological Association Journal. 2017;11:265.
24. Morini MA, Muller RL, de Castro Junior PCB, de Souza RJ, Faria EF. Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter? World journal of urology. 2018;36:1225-1231.
25. Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC, McKiernan JM. Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis. BJU international.2012;110:211-216.
26. Redaniel MT, Martin RM, Gillatt D, Wade J, Jeffreys M. Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study. BMC cancer. 2013;13:559.
27. Khan MA, Mangold LA, Epstein JI, Boitnott JK, Walsh PC, Partin AW. Impact of surgical delay on long-term cancer control for clinically localized prostate cancer. The Journal of urology.2004;172:1835-1839.
28. O’Brien D, Loeb S, Carvalhal GF, et al. Delay of surgery in men with low risk prostate cancer. The Journal of urology.2011;185:2143-2147.